β-Defensin 43 stands as a pivotal component in the intricate network of innate immunity, serving as an antimicrobial peptide with potent implications for host defense against various pathogens. Functionally, β-defensin 43 contributes to the innate immune response by exhibiting robust antimicrobial activity, acting as a frontline defender. The activation of β-defensin 43 involves a sophisticated orchestration of cellular signaling pathways influenced by diverse chemical activators. Compounds such as retinoic acid, thiazolidinedione, sulforaphane, butyrate, genistein, resveratrol, 5-azacytidine, alpha-lipoic acid, luteolin, diallyl disulfide, EGCG, and quercetin contribute to the up-regulation of β-defensin 43 through distinct mechanisms. Retinoic acid directly activates β-defensin 43 by binding to retinoic acid receptors (RARs), leading to enhanced transcription. Thiazolidinediones stimulate β-defensin 43 through PPARγ activation, strengthening the innate immune response. Sulforaphane activates β-defensin 43 via the Keap1-Nrf2-ARE pathway, contributing to antimicrobial defense. Butyrate acts as a histone deacetylase inhibitor, promoting an open chromatin structure and elevating β-defensin 43 expression.
Genistein indirectly activates β-defensin 43 by inhibiting the PI3K/Akt pathway, relieving FoxO3a-mediated transcriptional inhibition. Resveratrol modulates the Nrf2/ARE pathway, enhancing β-defensin 43 expression as an antioxidant. 5-Azacytidine directly activates β-defensin 43 by demethylating the promoter region, relieving epigenetic repression. Alpha-lipoic acid activates β-defensin 43 through the Nrf2/ARE pathway, contributing to antimicrobial defense. Luteolin modulates the AP-1 pathway, alleviating negative regulation on DEFB43 expression. Diallyl disulfide influences the MAPK pathway, enhancing β-defensin 43 transcription. EGCG inhibits the NF-κB pathway, leading to increased β-defensin 43 expression. Quercetin modulates the AP-1 pathway, positively regulating β-defensin 43 synthesis. The diversity in activation mechanisms underscores the complexity of innate immune responses and their implications for bolstering antimicrobial defenses. Understanding these intricacies not only sheds light on the regulation of β-defensin 43 but also opens avenues for manipulating innate immunity to enhance the host's ability to combat microbial challenges. The convergence of chemical activators highlights the intricate interplay of signaling pathways in regulating β-defensin 43, emphasizing its role as a pivotal component in the defense against microbial threats.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG activates β-defensin 43 by inhibiting the NF-κB pathway. It suppresses IκB kinase activity, preventing IκB degradation and subsequent NF-κB nuclear translocation. This down-regulation of NF-κB alleviates its suppression on DEFB43 transcription, leading to enhanced β-defensin 43 expression with implications for antimicrobial defense. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin stimulates β-defensin 43 indirectly by modulating the AP-1 pathway. It inhibits c-Fos and c-Jun activation, suppressing AP-1 transcriptional activity. As a consequence, the negative regulation on DEFB43 expression is alleviated, leading to increased β-defensin 43 synthesis with antimicrobial implications. | ||||||